Details 
We invite you to submit your poster presentation and register to attend the 3rd Annual CDD Community Meeting, a 1-day event on October 1st. The CDD Community Meeting is the best place for the CDD community and all scientists to get together, discuss their research projects, and showcase their work to others in the community.
Confirmed Speakers at this point:
- Christopher Lipinski, PhD, Adjunct Senior Research Fellow (ret.), Pfizer
- Ken Duncan, PhD, Senior Program Officer, Bill & Melinda Gates Foundation
- Chris Waller, PhD, Senior Director of Precompetitive Collaborations, Pfizer
- Tanya Parish, PhD, Acting Director of Drug Discovery, IDRI; Professor of Mycobacteriology, Queen Mary's School of Medicine
- Clifton Barry, PhD, Senior Investigator, NIAID/NIH
- Takushi Kaneko, PhD, Senior Project Leader, Chemistry, TB Alliance
- Andrea Altieri, PhD, Manager, Marketing & Project Development, ASINEX
We also have two panels lined up: one is focused on the advantages of data collaboration for commercial biotech companies. In contrast, the second panel is on our original area of focus on more neglected disease research.
For directions to/parking at the J. David Gladstone Institute, please click here:
There are many hotel options in downtown SF; we recommend the Courtyard Mariott as a good value.
We have reached full capacity on our number of registrations! Please contact Navin Kadaba (navin@collaborativedrug.com) to be put on our waitlist. You will be contacted 3 days before the event.
|
|
|
